MoonLake Immunotherapeutics · NASDAQ:MLTX

MoonLake Immunotherapeutics insider trades

MoonLake Immunotherapeutics's insiders made 0 buys and 23 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

Insider trades

TradeTradeSharesPriceValueDate
Reich Kristian
Officer: Chief Scientific Officer
Sale1,100USD 20.00US$22,000Jul 27, 2026
Reich Kristian
Officer: Chief Scientific Officer
Sale2,448USD 20.00US$48,960Jul 22, 2026
Reich Kristian
Officer: Chief Scientific Officer
Sale50,000USD 20.02US$1MJul 21, 2026
Reich Kristian
Officer: Chief Scientific Officer
Sale43,700USD 20.09US$878KJul 20, 2026
Reich Kristian
Officer: Chief Scientific Officer
Sale16,105USD 20.01US$322KJul 15, 2026
Santos da Silva Jorge
Director, Officer: Chief Executive Officer
Sale68,289USD 20.02US$1.37MJul 10, 2026
Santos da Silva Jorge
Director, Officer: Chief Executive Officer
Sale33,936USD 20.01US$679KJul 9, 2026
Santos da Silva Jorge
Director, Officer: Chief Executive Officer
Sale47,775USD 20.03US$957KJul 1, 2026
Bodenstedt Matthias
Officer: Chief Financial Officer
Sale39,120USD 22.04US$862KJun 22, 2026
Bodenstedt Matthias
Officer: Chief Financial Officer
Sale2,794USD 19.60US$54,762Jun 18, 2026
Bodenstedt Matthias
Officer: Chief Financial Officer
Sale15,082USD 19.68US$297KJun 17, 2026
Reich Kristian
Officer: Chief Scientific Officer
Sale50,000USD 19.43US$972KJun 17, 2026
Reich Kristian
Officer: Chief Scientific Officer
Sale50,000USD 18.70US$935KJun 16, 2026
Reich Kristian
Officer: Chief Scientific Officer
Sale50,000USD 18.89US$945KJun 15, 2026
Bodenstedt Matthias
Officer: Chief Financial Officer
Sale13,653USD 20.02US$273KMay 11, 2026
Bodenstedt Matthias
Officer: Chief Financial Officer
Sale2,426USD 19.56US$47,453Apr 14, 2026
Santos da Silva Jorge
Director, Officer: Chief Executive Officer
Sale51,873USD 18.23US$946KApr 13, 2026
Santos da Silva Jorge
Director, Officer: Chief Executive Officer
Sale98,127USD 18.41US$1.81MApr 10, 2026
Bodenstedt Matthias
Officer: Chief Financial Officer
Sale1,925USD 19.51US$37,557Apr 10, 2026
Bodenstedt Matthias
Officer: Chief Financial Officer
Sale85,870USD 18.94US$1.63MApr 9, 2026
Lampert Mark N
Director, 10% owner
Sale1,932,354USD 16.79US$32.4MMar 31, 2026
Lampert Mark N
Director, 10% owner
Sale1,569,116USD 16.79US$26.3MMar 31, 2026
Lampert Mark N
Director, 10% owner
Sale248,530USD 16.79US$4.17MMar 31, 2026

MoonLake Immunotherapeutics shareholders